• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

pharmaceutical contract manufacturing

Handshake
Manufacturing

Bushu and Amgen expand Asian contract manufacturing pact

Japan's Bushu Pharmaceuticals has expanded its Amgen partnership and expects to double the volume of Amgen products it makes and packages.
Fraiser Kansteiner Nov 24, 2021 11:15am
Fujifilm Irvine Scientific

Fujifilm completes construction of Netherlands production plant

Sep 30, 2021 10:30am
Fujifilm Diosynth Biotechnologies in Texas

Fujifilm blueprints $40M viral-vector production site in Boston

Jan 5, 2021 9:53am
Asia Map

Taiho, Otsuka, Chugai, Biocon and Mark Alles—FiercePharmaAsia

Jan 10, 2020 10:59am
Pills and vitamins

PCI debuts expansion of its Illinois facility

Dec 5, 2019 10:53am
Delpharm

France's Delpharm in talks to buy 5 Famar sites for $274M

Oct 4, 2019 10:12am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings